Linda Maxwell's most recent trade in United Therapeutics Corp was a trade of 1,190 Stock Option done . Disclosure was reported to the exchange on July 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2026 | 1,190 | 1,190 | - | - | Stock Option | |
| United Therapeutics Corp | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2026 | 380 | 380 | - | - | Restricted Stock Unit | |
| ImmunityBio Inc | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 65,600 | 65,600 | - | - | Stock Option (right to buy) | |
| United Therapeutics Corp | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2025 | 3,650 | 3,650 | - | - | Stock Options | |
| ImmunityBio Inc | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 162,786 | 162,786 | - | - | Stock Option (right to buy) | |
| United Therapeutics Corp | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 2,890 | 2,890 | - | - | Stock Options | |
| ImmunityBio Inc | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 77,633 | 77,633 | - | - | Stock Option (right to buy) | |
| United Therapeutics Corp | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 4,560 | 4,560 | - | - | Stock Options | |
| ImmunityBio Inc | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 158,263 | 158,263 | - | - | Stock Option (right to buy) | |
| United Therapeutics Corp | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 4,980 | 4,980 | - | - | Stock Options | |
| ImmunityBio Inc | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 167,937 | 167,937 | - | - | Stock Option (right to buy) | |
| United Therapeutics Corp | Linda Maxwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 102.44 per share. | 27 May 2022 | 2,000 | 2,000 (0%) | 0% | 102.4 | 204,880 | Common Stock |
| United Therapeutics Corp | Linda Maxwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2022 | 2,000 | 18,680 | - | - | Stock Options | |
| United Therapeutics Corp | Linda Maxwell | Director | Sale of securities on an exchange or to another person at price $ 228.00 per share. | 27 May 2022 | 2,000 | 0 (0%) | 0% | 228 | 456,000 | Common Stock |